Abstract
The condition of snakebite is recognized as a neglected disease, exerting a significant impact on public health. Despite the existence of a specific treatment, antivenom, it presents several disadvantages, including adverse effects and high costs. In this context, this study proposes the discovery of monoclonal antibodies (scFv) with cross-reactivity, targeting serine proteases from Bothr…